Herndon Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-139
Closed -$17K 203
2017
Q1
$17K Sell
139
-111
-44% -$13.1K ﹤0.01% 103
2016
Q4
$28K Sell
250
-122
-33% -$13.6K ﹤0.01% 87
2016
Q3
$44K Sell
372
-2,735
-88% -$322K ﹤0.01% 111
2016
Q2
$348K Sell
3,107
-2,138
-41% -$230K 0.01% 101
2016
Q1
$528K Sell
5,245
-653
-11% -$62.6K 0.01% 123
2015
Q4
$626K Sell
5,898
-3,192
-35% -$329K 0.01% 120
2015
Q3
$847K Sell
9,090
-4,061
-31% -$420K 0.02% 105
2015
Q2
$1.37M Buy
+13,151
New +$1.37M 0.02% 95

Other funds holding LH

Herndon Capital Management's LH Position: Q2 2017 in Review

Herndon Capital Management sold out of Labcorp (LH) in Q2 2017, closing a stake of 139 shares — an estimated $17K sold.

Herndon Capital Management first reported a position in LH in Q2 2015 and held it in 8 quarters. The position peaked at $1.37M in Q2 2015. 691 funds tracked by Wall St. Rank hold LH as of Q2 2017.

  • Herndon Capital Management reported no remaining Labcorp position as of Q2 2017 after selling out during the quarter.
  • Herndon Capital Management sold 139 Labcorp shares in Q2 2017, an estimated $17K.
  • Herndon Capital Management first reported a position in Labcorp in Q2 2015 and held it in 8 quarters.
  • Herndon Capital Management's Labcorp position peaked at $1.37M in Q2 2015.
  • 691 funds tracked by Wall St. Rank held Labcorp as of Q2 2017.

Based on Herndon Capital Management's 13F filing for Q2 2017, filed 4 Aug 2017.